Furthermore, we employed the same lightweight model to classify patient-derived lung cancer cells, both categorized as adenocarcinomas, with distinct genetic profiles: one harboring the KRAS oncogene (HCC 4087) and the other the EGFR oncogene (HCC 4190). This evidence concerns the gene KRAS and lung cancer.